image
Krystal Biotech, Inc. KRYS
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 148.39
2.47 %
$ 4.27 B
Market Cap
82.9
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jan, 18, 2025.

The intrinsic value of one KRYS stock under the worst case scenario is HIDDEN Compared to the current market price of 148 USD, Krystal Biotech, Inc. is HIDDEN

KRYS Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Jan, 18, 2025.

The intrinsic value of one KRYS stock under the base case scenario is HIDDEN Compared to the current market price of 148 USD, Krystal Biotech, Inc. is HIDDEN

KRYS Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Jan, 18, 2025.

The intrinsic value of one KRYS stock under the best case scenario is HIDDEN Compared to the current market price of 148 USD, Krystal Biotech, Inc. is HIDDEN

KRYS Intrinsic Value
HIDDEN
SHOW
2. FUNDAMENTAL ANALYSIS

Price Chart KRYS

image
1M -8%
6M -40%
1Y 16%
3Y 164%
5Y 173%
All
FINANCIALS
50.7 M REVENUE
0.00%
Growth Rates
1Year 0.00%
3Years 0.00%
5Years 118.12%
7Years 0.00%
10Years 0.00%
-110 M OPERATING INCOME
24.43%
Growth Rates
1Year 24.43%
3Years -49.26%
5Years -55.90%
7Years -91.95%
10Years 0.00%
10.9 M NET INCOME
107.81%
Growth Rates
1Year 107.81%
3Years 32.76%
5Years 24.61%
7Years 41.76%
10Years 0.00%
-88.8 M OPERATING CASH FLOW
11.70%
Growth Rates
1Year 11.70%
3Years -50.44%
5Years -56.55%
7Years -82.62%
10Years 0.00%
82.6 M INVESTING CASH FLOW
172.44%
Growth Rates
1Year 172.44%
3Years 110.98%
5Years 58.51%
7Years 242.34%
10Years 0.00%
203 M FINANCING CASH FLOW
473.60%
Growth Rates
1Year 473.60%
3Years 19.77%
5Years 22.38%
7Years 80.49%
10Years 0.00%
83.8 M REVENUE
19.29%
Growth Rates
1Year 0.00%
3Years 0.00%
5Years 118.12%
7Years 0.00%
10Years 0.00%
22.4 M OPERATING INCOME
6.49%
Growth Rates
1Year 24.43%
3Years -49.26%
5Years -55.90%
7Years -91.95%
10Years 0.00%
27.2 M NET INCOME
74.59%
Growth Rates
1Year 107.81%
3Years 32.76%
5Years 24.61%
7Years 41.76%
10Years 0.00%
58.9 M OPERATING CASH FLOW
1512.12%
Growth Rates
1Year 11.70%
3Years -50.44%
5Years -56.55%
7Years -82.62%
10Years 0.00%
-34.3 M INVESTING CASH FLOW
-77.38%
Growth Rates
1Year 172.44%
3Years 110.98%
5Years 58.51%
7Years 242.34%
10Years 0.00%
3.36 M FINANCING CASH FLOW
-68.37%
Growth Rates
1Year 473.60%
3Years 19.77%
5Years 22.38%
7Years 80.49%
10Years 0.00%
Balance Sheet Krystal Biotech, Inc.
image
Current Assets 588 M
Cash & Short-Term Investments 532 M
Receivables 42 M
Other Current Assets 13.7 M
Non-Current Assets 230 M
Long-Term Investments 62 M
PP&E 168 M
Other Non-Current Assets 263 K
Current Liabilities 33.1 M
Accounts Payable 1.85 M
Short-Term Debt 1.47 M
Other Current Liabilities 29.8 M
Non-Current Liabilities 6.62 M
Long-Term Debt 6.62 M
Other Non-Current Liabilities 0
EFFICIENCY
Earnings Waterfall Krystal Biotech, Inc.
image
Revenue 50.7 M
Cost Of Revenue 3.09 M
Gross Profit 47.6 M
Operating Expenses 157 M
Operating Income -110 M
Other Expenses -121 M
Net Income 10.9 M
RATIOS
93.90% GROSS MARGIN
93.90%
Averages
1Year 93.90%
3Years 31.30%
5Years 18.78%
7Years 25.74%
10Years 0.00%
-216.43% OPERATING MARGIN
-216.43%
Averages
1Year -216.43%
3Years -72.14%
5Years -43.29%
7Years -196.67%
10Years 0.00%
21.56% NET MARGIN
21.56%
Averages
1Year 21.56%
3Years 7.19%
5Years 4.31%
7Years -148.39%
10Years 0.00%
1.40% ROE
1.40%
Averages
1Year 1.40%
3Years -12.37%
5Years -11.51%
7Years -11.88%
10Years 0.00%
1.34% ROA
1.34%
Averages
1Year 1.34%
3Years -11.61%
5Years -10.86%
7Years -11.36%
10Years 0.00%
-11.95% ROIC
-11.95%
Averages
1Year -11.95%
3Years -19.45%
5Years -16.22%
7Years -14.46%
10Years 0.00%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Krystal Biotech, Inc.
image
Net Income 10.9 M
Depreciation & Amortization 5.01 M
Capital Expenditures -11.8 M
Stock-Based Compensation 39.9 M
Change in Working Capital -37.9 M
Others -98.1 M
Free Cash Flow -101 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Krystal Biotech, Inc.
image
Wall Street analysts predict an average 1-year price target for KRYS of $209 , with forecasts ranging from a low of $204 to a high of $220 .
KRYS Lowest Price Target Wall Street Target
204 USD 37.48%
KRYS Average Price Target Wall Street Target
209 USD 40.68%
KRYS Highest Price Target Wall Street Target
220 USD 48.26%
4. DIVIDEND ANALYSIS
5. COMPETITION

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative diseases, such as amyotrophic lateral sclerosis; and Parkinson's diseases.

image
-228 USD
MGTX
Overvalued 3747.64%

Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases.

image
-703 USD
APLS
Overvalued 2447.06%

REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease.

image
-669 USD
RGNX
Overvalued 9175.13%

Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity.

image
-322 USD
RYTM
Overvalued 689.94%
6. Ownership
Insider Ownership Krystal Biotech, Inc.
image
Sold
0-3 MONTHS
16.5 M USD 2
3-6 MONTHS
19.8 M USD 2
6-9 MONTHS
20.9 M USD 3
9-12 MONTHS
20.6 M USD 4
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
1 month ago
Dec 13, 2024
Sell 1.03 M USD
Krishnan Suma
President, R&D
- 6302
 163.069 USD
1 month ago
Dec 13, 2024
Sell 1.37 M USD
Krishnan Suma
President, R&D
- 8381
 163.9131 USD
1 month ago
Dec 13, 2024
Sell 810 K USD
Krishnan Suma
President, R&D
- 4909
 164.9306 USD
1 month ago
Dec 13, 2024
Sell 328 K USD
Krishnan Suma
President, R&D
- 1977
 165.8235 USD
1 month ago
Dec 13, 2024
Sell 154 K USD
Krishnan Suma
President, R&D
- 923
 166.9274 USD
1 month ago
Dec 13, 2024
Sell 155 K USD
Krishnan Suma
President, R&D
- 911
 169.6484 USD
1 month ago
Dec 13, 2024
Sell 163 K USD
Krishnan Suma
President, R&D
- 957
 170.4687 USD
1 month ago
Dec 13, 2024
Sell 110 K USD
Krishnan Suma
President, R&D
- 640
 171.6288 USD
1 month ago
Dec 13, 2024
Sell 969 K USD
Krishnan Suma
President, R&D
- 5942
 163.0435 USD
1 month ago
Dec 13, 2024
Sell 1.46 M USD
Krishnan Suma
President, R&D
- 8923
 163.9154 USD
1 month ago
Dec 13, 2024
Sell 779 K USD
Krishnan Suma
President, R&D
- 4723
 164.915 USD
1 month ago
Dec 13, 2024
Sell 350 K USD
Krishnan Suma
President, R&D
- 2114
 165.7947 USD
1 month ago
Dec 13, 2024
Sell 133 K USD
Krishnan Suma
President, R&D
- 798
 166.9582 USD
1 month ago
Dec 13, 2024
Sell 33.7 K USD
Krishnan Suma
President, R&D
- 200
 168.3103 USD
1 month ago
Dec 13, 2024
Sell 162 K USD
Krishnan Suma
President, R&D
- 953
 169.4802 USD
1 month ago
Dec 13, 2024
Sell 124 K USD
Krishnan Suma
President, R&D
- 727
 170.4303 USD
1 month ago
Dec 13, 2024
Sell 106 K USD
Krishnan Suma
President, R&D
- 620
 171.6245 USD
1 month ago
Dec 13, 2024
Sell 1.03 M USD
Krishnan Krish S
President and CEO
- 6302
 163.069 USD
1 month ago
Dec 13, 2024
Sell 1.37 M USD
Krishnan Krish S
President and CEO
- 8381
 163.9131 USD
1 month ago
Dec 13, 2024
Sell 810 K USD
Krishnan Krish S
President and CEO
- 4909
 164.9306 USD
1 month ago
Dec 13, 2024
Sell 328 K USD
Krishnan Krish S
President and CEO
- 1977
 165.8235 USD
1 month ago
Dec 13, 2024
Sell 154 K USD
Krishnan Krish S
President and CEO
- 923
 166.9274 USD
1 month ago
Dec 13, 2024
Sell 155 K USD
Krishnan Krish S
President and CEO
- 911
 169.6484 USD
1 month ago
Dec 13, 2024
Sell 163 K USD
Krishnan Krish S
President and CEO
- 957
 170.4687 USD
1 month ago
Dec 13, 2024
Sell 110 K USD
Krishnan Krish S
President and CEO
- 640
 171.6288 USD
1 month ago
Dec 13, 2024
Sell 969 K USD
Krishnan Krish S
President and CEO
- 5942
 163.0435 USD
1 month ago
Dec 13, 2024
Sell 1.46 M USD
Krishnan Krish S
President and CEO
- 8923
 163.9154 USD
1 month ago
Dec 13, 2024
Sell 779 K USD
Krishnan Krish S
President and CEO
- 4723
 164.915 USD
1 month ago
Dec 13, 2024
Sell 350 K USD
Krishnan Krish S
President and CEO
- 2114
 165.7947 USD
1 month ago
Dec 13, 2024
Sell 133 K USD
Krishnan Krish S
President and CEO
- 798
 166.9582 USD
1 month ago
Dec 13, 2024
Sell 33.7 K USD
Krishnan Krish S
President and CEO
- 200
 168.3103 USD
1 month ago
Dec 13, 2024
Sell 162 K USD
Krishnan Krish S
President and CEO
- 953
 169.4802 USD
1 month ago
Dec 13, 2024
Sell 124 K USD
Krishnan Krish S
President and CEO
- 727
 170.4303 USD
1 month ago
Dec 13, 2024
Sell 106 K USD
Krishnan Krish S
President and CEO
- 620
 171.6245 USD
4 months ago
Sep 12, 2024
Sell 772 K USD
Krishnan Suma
President, R&D
- 3957
 195.1627 USD
4 months ago
Sep 12, 2024
Sell 1.26 M USD
Krishnan Suma
President, R&D
- 6458
 195.7226 USD
4 months ago
Sep 12, 2024
Sell 334 K USD
Krishnan Suma
President, R&D
- 1696
 197.0387 USD
4 months ago
Sep 12, 2024
Sell 413 K USD
Krishnan Suma
President, R&D
- 2086
 198.0803 USD
4 months ago
Sep 12, 2024
Sell 797 K USD
Krishnan Suma
President, R&D
- 4008
 198.9264 USD
4 months ago
Sep 12, 2024
Sell 721 K USD
Krishnan Suma
President, R&D
- 3600
 200.1522 USD
4 months ago
Sep 12, 2024
Sell 481 K USD
Krishnan Suma
President, R&D
- 2395
 200.9758 USD
4 months ago
Sep 12, 2024
Sell 161 K USD
Krishnan Suma
President, R&D
- 800
 201.8085 USD
4 months ago
Sep 12, 2024
Sell 1.66 M USD
Krishnan Suma
President, R&D
- 8497
 195.4297 USD
4 months ago
Sep 12, 2024
Sell 535 K USD
Krishnan Suma
President, R&D
- 2727
 196.0668 USD
4 months ago
Sep 12, 2024
Sell 274 K USD
Krishnan Suma
President, R&D
- 1385
 197.5454 USD
4 months ago
Sep 12, 2024
Sell 673 K USD
Krishnan Suma
President, R&D
- 3392
 198.433 USD
4 months ago
Sep 12, 2024
Sell 587 K USD
Krishnan Suma
President, R&D
- 2945
 199.2231 USD
4 months ago
Sep 12, 2024
Sell 834 K USD
Krishnan Suma
President, R&D
- 4159
 200.4149 USD
4 months ago
Sep 12, 2024
Sell 382 K USD
Krishnan Suma
President, R&D
- 1895
 201.5177 USD
4 months ago
Sep 12, 2024
Sell 772 K USD
Krishnan Krish S
President and CEO
- 3957
 195.1627 USD
4 months ago
Sep 12, 2024
Sell 1.26 M USD
Krishnan Krish S
President and CEO
- 6458
 195.7226 USD
4 months ago
Sep 12, 2024
Sell 334 K USD
Krishnan Krish S
President and CEO
- 1696
 197.0387 USD
4 months ago
Sep 12, 2024
Sell 413 K USD
Krishnan Krish S
President and CEO
- 2086
 198.0803 USD
4 months ago
Sep 12, 2024
Sell 797 K USD
Krishnan Krish S
President and CEO
- 4008
 198.9264 USD
4 months ago
Sep 12, 2024
Sell 721 K USD
Krishnan Krish S
President and CEO
- 3600
 200.1522 USD
4 months ago
Sep 12, 2024
Sell 481 K USD
Krishnan Krish S
President and CEO
- 2395
 200.9758 USD
4 months ago
Sep 12, 2024
Sell 161 K USD
Krishnan Krish S
President and CEO
- 800
 201.8085 USD
4 months ago
Sep 12, 2024
Sell 1.66 M USD
Krishnan Krish S
President and CEO
- 8497
 195.4297 USD
4 months ago
Sep 12, 2024
Sell 535 K USD
Krishnan Krish S
President and CEO
- 2727
 196.0668 USD
4 months ago
Sep 12, 2024
Sell 274 K USD
Krishnan Krish S
President and CEO
- 1385
 197.5454 USD
4 months ago
Sep 12, 2024
Sell 673 K USD
Krishnan Krish S
President and CEO
- 3392
 198.433 USD
4 months ago
Sep 12, 2024
Sell 587 K USD
Krishnan Krish S
President and CEO
- 2945
 199.2231 USD
4 months ago
Sep 12, 2024
Sell 834 K USD
Krishnan Krish S
President and CEO
- 4159
 200.4149 USD
4 months ago
Sep 12, 2024
Sell 382 K USD
Krishnan Krish S
President and CEO
- 1895
 201.5177 USD
7 months ago
Jun 11, 2024
Sell 189 K USD
Krishnan Suma
President, R&D
- 1100
 171.488 USD
7 months ago
Jun 11, 2024
Sell 324 K USD
Krishnan Suma
President, R&D
- 1882
 172.2128 USD
7 months ago
Jun 11, 2024
Sell 229 K USD
Krishnan Suma
President, R&D
- 1318
 173.4875 USD
7 months ago
Jun 11, 2024
Sell 699 K USD
Krishnan Suma
President, R&D
- 4000
 174.8261 USD
7 months ago
Jun 11, 2024
Sell 800 K USD
Krishnan Suma
President, R&D
- 4550
 175.7568 USD
7 months ago
Jun 11, 2024
Sell 1.01 M USD
Krishnan Suma
President, R&D
- 5705
 176.6786 USD
7 months ago
Jun 11, 2024
Sell 968 K USD
Krishnan Suma
President, R&D
- 5447
 177.6784 USD
7 months ago
Jun 11, 2024
Sell 178 K USD
Krishnan Suma
President, R&D
- 998
 178.3564 USD
7 months ago
Jun 11, 2024
Sell 154 K USD
Krishnan Suma
President, R&D
- 900
 171.3962 USD
7 months ago
Jun 11, 2024
Sell 362 K USD
Krishnan Suma
President, R&D
- 2099
 172.2385 USD
7 months ago
Jun 11, 2024
Sell 209 K USD
Krishnan Suma
President, R&D
- 1206
 173.414 USD
7 months ago
Jun 11, 2024
Sell 301 K USD
Krishnan Suma
President, R&D
- 1724
 174.4962 USD
7 months ago
Jun 11, 2024
Sell 872 K USD
Krishnan Suma
President, R&D
- 4975
 175.3313 USD
7 months ago
Jun 11, 2024
Sell 1.03 M USD
Krishnan Suma
President, R&D
- 5867
 176.375 USD
7 months ago
Jun 11, 2024
Sell 1.13 M USD
Krishnan Suma
President, R&D
- 6358
 177.3785 USD
7 months ago
Jun 11, 2024
Sell 333 K USD
Krishnan Suma
President, R&D
- 1871
 178.1447 USD
7 months ago
Jun 11, 2024
Sell 189 K USD
Krishnan Krish S
President and CEO
- 1100
 171.488 USD
7 months ago
Jun 11, 2024
Sell 324 K USD
Krishnan Krish S
President and CEO
- 1882
 172.2128 USD
7 months ago
Jun 11, 2024
Sell 229 K USD
Krishnan Krish S
President and CEO
- 1318
 173.4875 USD
7 months ago
Jun 11, 2024
Sell 699 K USD
Krishnan Krish S
President and CEO
- 4000
 174.8261 USD
7 months ago
Jun 11, 2024
Sell 800 K USD
Krishnan Krish S
President and CEO
- 4550
 175.7568 USD
7 months ago
Jun 11, 2024
Sell 1.01 M USD
Krishnan Krish S
President and CEO
- 5705
 176.6786 USD
7 months ago
Jun 11, 2024
Sell 968 K USD
Krishnan Krish S
President and CEO
- 5447
 177.6784 USD
7 months ago
Jun 11, 2024
Sell 178 K USD
Krishnan Krish S
President and CEO
- 998
 178.3564 USD
7 months ago
Jun 11, 2024
Sell 154 K USD
Krishnan Krish S
President and CEO
- 900
 171.3962 USD
7 months ago
Jun 11, 2024
Sell 362 K USD
Krishnan Krish S
President and CEO
- 2099
 172.2385 USD
7 months ago
Jun 11, 2024
Sell 209 K USD
Krishnan Krish S
President and CEO
- 1206
 173.414 USD
7 months ago
Jun 11, 2024
Sell 301 K USD
Krishnan Krish S
President and CEO
- 1724
 174.4962 USD
7 months ago
Jun 11, 2024
Sell 872 K USD
Krishnan Krish S
President and CEO
- 4975
 175.3313 USD
7 months ago
Jun 11, 2024
Sell 1.03 M USD
Krishnan Krish S
President and CEO
- 5867
 176.375 USD
7 months ago
Jun 11, 2024
Sell 1.13 M USD
Krishnan Krish S
President and CEO
- 6358
 177.3785 USD
7 months ago
Jun 11, 2024
Sell 333 K USD
Krishnan Krish S
President and CEO
- 1871
 178.1447 USD
8 months ago
May 20, 2024
Sell 1.79 M USD
Gangolli Julian S
Director
- 10930
 163.7063 USD
8 months ago
May 20, 2024
Sell 1.17 M USD
Gangolli Julian S
Director
- 7090
 164.3413 USD
8 months ago
May 20, 2024
Sell 328 K USD
Gangolli Julian S
Director
- 1980
 165.7576 USD
10 months ago
Mar 11, 2024
Sell 361 K USD
Krishnan Suma
President, R&D
- 2146
 167.9922 USD
10 months ago
Mar 11, 2024
Sell 381 K USD
Krishnan Suma
President, R&D
- 2254
 168.8822 USD
10 months ago
Mar 11, 2024
Sell 870 K USD
Krishnan Suma
President, R&D
- 5109
 170.3241 USD
10 months ago
Mar 11, 2024
Sell 1.37 M USD
Krishnan Suma
President, R&D
- 8002
 170.9285 USD
10 months ago
Mar 11, 2024
Sell 485 K USD
Krishnan Suma
President, R&D
- 2816
 172.0593 USD
10 months ago
Mar 11, 2024
Sell 581 K USD
Krishnan Suma
President, R&D
- 3359
 173.0879 USD
10 months ago
Mar 11, 2024
Sell 229 K USD
Krishnan Suma
President, R&D
- 1314
 173.9959 USD
10 months ago
Mar 11, 2024
Sell 447 K USD
Krishnan Suma
President, R&D
- 2658
 168.1508 USD
10 months ago
Mar 11, 2024
Sell 278 K USD
Krishnan Suma
President, R&D
- 1646
 168.9574 USD
10 months ago
Mar 11, 2024
Sell 1.37 M USD
Krishnan Suma
President, R&D
- 8040
 170.4196 USD
10 months ago
Mar 11, 2024
Sell 936 K USD
Krishnan Suma
President, R&D
- 5469
 171.0939 USD
10 months ago
Mar 11, 2024
Sell 482 K USD
Krishnan Suma
President, R&D
- 2800
 172.2057 USD
10 months ago
Mar 11, 2024
Sell 622 K USD
Krishnan Suma
President, R&D
- 3587
 173.2991 USD
10 months ago
Mar 11, 2024
Sell 139 K USD
Krishnan Suma
President, R&D
- 800
 174.1313 USD
10 months ago
Mar 11, 2024
Sell 361 K USD
Krishnan Krish S
President and CEO
- 2146
 167.9922 USD
10 months ago
Mar 11, 2024
Sell 381 K USD
Krishnan Krish S
President and CEO
- 2254
 168.8822 USD
10 months ago
Mar 11, 2024
Sell 870 K USD
Krishnan Krish S
President and CEO
- 5109
 170.3241 USD
10 months ago
Mar 11, 2024
Sell 1.37 M USD
Krishnan Krish S
President and CEO
- 8002
 170.9285 USD
10 months ago
Mar 11, 2024
Sell 485 K USD
Krishnan Krish S
President and CEO
- 2816
 172.0593 USD
10 months ago
Mar 11, 2024
Sell 581 K USD
Krishnan Krish S
President and CEO
- 3359
 173.0879 USD
10 months ago
Mar 11, 2024
Sell 229 K USD
Krishnan Krish S
President and CEO
- 1314
 173.9959 USD
10 months ago
Mar 11, 2024
Sell 447 K USD
Krishnan Krish S
President and CEO
- 2658
 168.1508 USD
10 months ago
Mar 11, 2024
Sell 278 K USD
Krishnan Krish S
President and CEO
- 1646
 168.9574 USD
10 months ago
Mar 11, 2024
Sell 1.37 M USD
Krishnan Krish S
President and CEO
- 8040
 170.4196 USD
10 months ago
Mar 11, 2024
Sell 936 K USD
Krishnan Krish S
President and CEO
- 5469
 171.0939 USD
10 months ago
Mar 11, 2024
Sell 482 K USD
Krishnan Krish S
President and CEO
- 2800
 172.2057 USD
10 months ago
Mar 11, 2024
Sell 622 K USD
Krishnan Krish S
President and CEO
- 3587
 173.2991 USD
10 months ago
Mar 11, 2024
Sell 139 K USD
Krishnan Krish S
President and CEO
- 800
 174.1313 USD
10 months ago
Feb 28, 2024
Sell 105 K USD
ROMANO KATHRYN
Chief Accounting Officer
- 648
 162.7102 USD
10 months ago
Feb 28, 2024
Sell 147 K USD
ROMANO KATHRYN
Chief Accounting Officer
- 900
 163.6756 USD
10 months ago
Feb 28, 2024
Sell 236 K USD
ROMANO KATHRYN
Chief Accounting Officer
- 1429
 164.8075 USD
10 months ago
Feb 28, 2024
Sell 49.8 K USD
ROMANO KATHRYN
Chief Accounting Officer
- 300
 166.0633 USD
10 months ago
Feb 28, 2024
Sell 206 K USD
ROMANO KATHRYN
Chief Accounting Officer
- 1216
 169.0946 USD
10 months ago
Feb 28, 2024
Sell 19.9 K USD
ROMANO KATHRYN
Chief Accounting Officer
- 117
 169.8205 USD
10 months ago
Feb 28, 2024
Sell 15.5 K USD
ROMANO KATHRYN
Chief Accounting Officer
- 90
 172.23 USD
10 months ago
Feb 28, 2024
Sell 85.3 K USD
ROMANO KATHRYN
Chief Accounting Officer
- 523
 163.134 USD
10 months ago
Feb 28, 2024
Sell 122 K USD
ROMANO KATHRYN
Chief Accounting Officer
- 744
 164.6031 USD
10 months ago
Feb 28, 2024
Sell 21.5 K USD
ROMANO KATHRYN
Chief Accounting Officer
- 130
 165.2197 USD
10 months ago
Feb 28, 2024
Sell 16.6 K USD
ROMANO KATHRYN
Chief Accounting Officer
- 100
 166.215 USD
10 months ago
Feb 28, 2024
Sell 118 K USD
ROMANO KATHRYN
Chief Accounting Officer
- 700
 168.9136 USD
10 months ago
Feb 28, 2024
Sell 34.4 K USD
ROMANO KATHRYN
Chief Accounting Officer
- 203
 169.468 USD
10 months ago
Feb 28, 2024
Sell 17.1 K USD
ROMANO KATHRYN
Chief Accounting Officer
- 100
 171.45 USD
10 months ago
Feb 28, 2024
Sell 104 K USD
ROMANO KATHRYN
Chief Accounting Officer
- 637
 162.7254 USD
10 months ago
Feb 28, 2024
Sell 129 K USD
ROMANO KATHRYN
Chief Accounting Officer
- 786
 163.4937 USD
10 months ago
Feb 28, 2024
Sell 264 K USD
ROMANO KATHRYN
Chief Accounting Officer
- 1600
 164.8444 USD
10 months ago
Feb 28, 2024
Sell 33.2 K USD
ROMANO KATHRYN
Chief Accounting Officer
- 200
 166.04 USD
10 months ago
Feb 28, 2024
Sell 50.4 K USD
ROMANO KATHRYN
Chief Accounting Officer
- 300
 167.85 USD
10 months ago
Feb 28, 2024
Sell 192 K USD
ROMANO KATHRYN
Chief Accounting Officer
- 1133
 169.095 USD
10 months ago
Feb 28, 2024
Sell 35.6 K USD
ROMANO KATHRYN
Chief Accounting Officer
- 210
 169.751 USD
10 months ago
Feb 28, 2024
Sell 23 K USD
ROMANO KATHRYN
Chief Accounting Officer
- 134
 171.6554 USD
10 months ago
Feb 26, 2024
Sell 432 K USD
ROMANO KATHRYN
Chief Accounting Officer
- 3087
 140 USD
10 months ago
Feb 26, 2024
Sell 675 K USD
ROMANO KATHRYN
Chief Accounting Officer
- 5000
 135 USD
11 months ago
Jan 22, 2024
Sell 325 K USD
Romano Kathryn
Chief Accounting Officer
- 2500
 130 USD
1 year ago
Dec 11, 2023
Sell 459 K USD
Krishnan Suma
President, R&D
- 4400
 104.4146 USD
1 year ago
Dec 11, 2023
Sell 661 K USD
Krishnan Suma
President, R&D
- 6263
 105.5039 USD
1 year ago
Dec 11, 2023
Sell 1.51 M USD
Krishnan Suma
President, R&D
- 14237
 106.1085 USD
1 year ago
Dec 11, 2023
Sell 10.8 K USD
Krishnan Suma
President, R&D
- 100
 107.66 USD
1 year ago
Dec 11, 2023
Sell 298 K USD
Krishnan Suma
President, R&D
- 2854
 104.2639 USD
1 year ago
Dec 11, 2023
Sell 477 K USD
Krishnan Suma
President, R&D
- 4541
 105.0621 USD
1 year ago
Dec 11, 2023
Sell 1.86 M USD
Krishnan Suma
President, R&D
- 17505
 106.0406 USD
1 year ago
Dec 11, 2023
Sell 10.8 K USD
Krishnan Suma
President, R&D
- 100
 107.66 USD
1 year ago
Dec 11, 2023
Sell 459 K USD
Krishnan Krish S
President and CEO
- 4400
 104.4146 USD
1 year ago
Dec 11, 2023
Sell 661 K USD
Krishnan Krish S
President and CEO
- 6263
 105.5039 USD
1 year ago
Dec 11, 2023
Sell 1.51 M USD
Krishnan Krish S
President and CEO
- 14237
 106.1085 USD
1 year ago
Dec 11, 2023
Sell 10.8 K USD
Krishnan Krish S
President and CEO
- 100
 107.66 USD
1 year ago
Dec 11, 2023
Sell 298 K USD
Krishnan Krish S
President and CEO
- 2854
 104.2639 USD
1 year ago
Dec 11, 2023
Sell 477 K USD
Krishnan Krish S
President and CEO
- 4541
 105.0621 USD
1 year ago
Dec 11, 2023
Sell 1.86 M USD
Krishnan Krish S
President and CEO
- 17505
 106.0406 USD
1 year ago
Dec 11, 2023
Sell 10.8 K USD
Krishnan Krish S
President and CEO
- 100
 107.66 USD
1 year ago
Sep 11, 2023
Sell 627 K USD
Krishnan Suma
President, R&D
- 5008
 125.2275 USD
1 year ago
Sep 11, 2023
Sell 688 K USD
Krishnan Suma
President, R&D
- 5452
 126.1677 USD
1 year ago
Sep 11, 2023
Sell 238 K USD
Krishnan Suma
President, R&D
- 1873
 127.1832 USD
1 year ago
Sep 11, 2023
Sell 1.36 M USD
Krishnan Suma
President, R&D
- 10557
 128.3713 USD
1 year ago
Sep 11, 2023
Sell 272 K USD
Krishnan Suma
President, R&D
- 2110
 129.1013 USD
1 year ago
Sep 11, 2023
Sell 627 K USD
Krishnan Suma
President, R&D
- 5007
 125.2275 USD
1 year ago
Sep 11, 2023
Sell 688 K USD
Krishnan Suma
President, R&D
- 5452
 126.1676 USD
1 year ago
Sep 11, 2023
Sell 238 K USD
Krishnan Suma
President, R&D
- 1874
 127.1833 USD
1 year ago
Sep 11, 2023
Sell 1.36 M USD
Krishnan Suma
President, R&D
- 10557
 128.3713 USD
1 year ago
Sep 11, 2023
Sell 272 K USD
Krishnan Suma
President, R&D
- 2110
 129.1014 USD
1 year ago
Sep 11, 2023
Sell 627 K USD
Krishnan Krish S
President and CEO
- 5008
 125.2275 USD
1 year ago
Sep 11, 2023
Sell 688 K USD
Krishnan Krish S
President and CEO
- 5452
 126.1677 USD
1 year ago
Sep 11, 2023
Sell 238 K USD
Krishnan Krish S
President and CEO
- 1873
 127.1832 USD
1 year ago
Sep 11, 2023
Sell 1.36 M USD
Krishnan Krish S
President and CEO
- 10557
 128.3713 USD
1 year ago
Sep 11, 2023
Sell 272 K USD
Krishnan Krish S
President and CEO
- 2110
 129.1013 USD
1 year ago
Sep 11, 2023
Sell 627 K USD
Krishnan Krish S
President and CEO
- 5007
 125.2275 USD
1 year ago
Sep 11, 2023
Sell 688 K USD
Krishnan Krish S
President and CEO
- 5452
 126.1676 USD
1 year ago
Sep 11, 2023
Sell 238 K USD
Krishnan Krish S
President and CEO
- 1874
 127.1833 USD
1 year ago
Sep 11, 2023
Sell 1.36 M USD
Krishnan Krish S
President and CEO
- 10557
 128.3713 USD
1 year ago
Sep 11, 2023
Sell 272 K USD
Krishnan Krish S
President and CEO
- 2110
 129.1014 USD
1 year ago
Jun 08, 2023
Sell 589 K USD
JANNEY DANIEL
Director
- 4604
 127.9578 USD
1 year ago
Jun 08, 2023
Sell 138 K USD
JANNEY DANIEL
Director
- 1073
 129.0218 USD
1 year ago
Jun 08, 2023
Sell 694 K USD
JANNEY DANIEL
Director
- 5388
 128.7335 USD
1 year ago
Jun 08, 2023
Sell 640 K USD
JANNEY DANIEL
Director
- 5000
 127.958 USD
1 year ago
Jun 08, 2023
Sell 1.28 M USD
JANNEY DANIEL
Director
- 10000
 127.9584 USD
1 year ago
Jun 08, 2023
Sell 639 K USD
JANNEY DANIEL
Director
- 5000
 127.8612 USD
1 year ago
Jun 09, 2023
Sell 509 K USD
JANNEY DANIEL
Director
- 3935
 129.2943 USD
1 year ago
Jun 09, 2023
Sell 644 K USD
JANNEY DANIEL
Director
- 5000
 128.8375 USD
1 year ago
Jun 09, 2023
Sell 1.29 M USD
JANNEY DANIEL
Director
- 10000
 128.5262 USD
1 year ago
Jun 09, 2023
Sell 674 K USD
ORTH ANDREW C.
Chief Commercial Officer
- 5261
 128.1045 USD
1 year ago
Jun 09, 2023
Sell 890 K USD
ORTH ANDREW C.
Chief Commercial Officer
- 6906
 128.9441 USD
1 year ago
Jun 09, 2023
Sell 43.2 K USD
ORTH ANDREW C.
Chief Commercial Officer
- 333
 129.6972 USD
1 year ago
May 31, 2023
Sell 2.19 M USD
Krishnan Suma
President, R&D
- 18884
 115.995 USD
1 year ago
May 31, 2023
Sell 668 K USD
Krishnan Suma
President, R&D
- 5716
 116.9498 USD
1 year ago
May 31, 2023
Sell 47 K USD
Krishnan Suma
President, R&D
- 400
 117.605 USD
1 year ago
May 31, 2023
Sell 2.34 M USD
Krishnan Suma
President, R&D
- 20143
 115.9757 USD
1 year ago
May 31, 2023
Sell 533 K USD
Krishnan Suma
President, R&D
- 4557
 116.8624 USD
1 year ago
May 31, 2023
Sell 35.3 K USD
Krishnan Suma
President, R&D
- 300
 117.5733 USD
1 year ago
May 31, 2023
Sell 2.19 M USD
Krishnan Krish S
President and CEO
- 18884
 115.995 USD
1 year ago
May 31, 2023
Sell 668 K USD
Krishnan Krish S
President and CEO
- 5716
 116.9498 USD
1 year ago
May 31, 2023
Sell 47 K USD
Krishnan Krish S
President and CEO
- 400
 117.605 USD
1 year ago
May 31, 2023
Sell 2.34 M USD
Krishnan Krish S
President and CEO
- 20143
 115.9757 USD
1 year ago
May 31, 2023
Sell 533 K USD
Krishnan Krish S
President and CEO
- 4557
 116.8624 USD
1 year ago
May 31, 2023
Sell 35.3 K USD
Krishnan Krish S
President and CEO
- 300
 117.5733 USD
1 year ago
May 19, 2023
Sell 1.19 M USD
Romano Kathryn
Chief Accounting Officer
- 12500
 95.05 USD
1 year ago
May 19, 2023
Sell 1.19 M USD
Romano Kathryn
Chief Accounting Officer
- 12500
 95.0449 USD
1 year ago
May 19, 2023
Sell 326 K USD
Romano Kathryn
Chief Accounting Officer
- 3428
 95.0808 USD
1 year ago
May 22, 2023
Sell 267 K USD
Romano Kathryn
Chief Accounting Officer
- 2521
 105.8036 USD
1 year ago
May 22, 2023
Sell 274 K USD
Romano Kathryn
Chief Accounting Officer
- 2570
 106.8087 USD
1 year ago
May 22, 2023
Sell 140 K USD
Romano Kathryn
Chief Accounting Officer
- 1300
 107.8777 USD
1 year ago
May 22, 2023
Sell 323 K USD
Romano Kathryn
Chief Accounting Officer
- 2955
 109.1719 USD
1 year ago
May 22, 2023
Sell 347 K USD
Romano Kathryn
Chief Accounting Officer
- 3154
 109.9933 USD
1 year ago
May 22, 2023
Sell 1.38 M USD
Romano Kathryn
Chief Accounting Officer
- 12500
 110 USD
1 year ago
May 19, 2023
Sell 4.75 M USD
JANNEY DANIEL
Director
- 50000
 95.0237 USD
1 year ago
May 09, 2023
Sell 1.55 M USD
JANNEY DANIEL
Director
- 17100
 90.7356 USD
1 year ago
Apr 19, 2023
Sell 713 K USD
JANNEY DANIEL
Director
- 7900
 90.3156 USD
1 year ago
Apr 17, 2023
Sell 89.8 K USD
Krishnan Suma
President, R&D
- 1050
 85.5483 USD
1 year ago
Apr 17, 2023
Sell 373 K USD
Krishnan Suma
President, R&D
- 4298
 86.7964 USD
1 year ago
Apr 17, 2023
Sell 824 K USD
Krishnan Suma
President, R&D
- 9428
 87.4113 USD
1 year ago
Apr 17, 2023
Sell 860 K USD
Krishnan Suma
President, R&D
- 9724
 88.4062 USD
1 year ago
Apr 17, 2023
Sell 44.6 K USD
Krishnan Suma
President, R&D
- 500
 89.1175 USD
1 year ago
Apr 17, 2023
Sell 89.8 K USD
Krishnan Suma
President, R&D
- 1050
 85.5487 USD
1 year ago
Apr 17, 2023
Sell 373 K USD
Krishnan Suma
President, R&D
- 4297
 86.7964 USD
1 year ago
Apr 17, 2023
Sell 824 K USD
Krishnan Suma
President, R&D
- 9429
 87.4114 USD
1 year ago
Apr 17, 2023
Sell 860 K USD
Krishnan Suma
President, R&D
- 9724
 88.4062 USD
1 year ago
Apr 17, 2023
Sell 44.6 K USD
Krishnan Suma
President, R&D
- 500
 89.1175 USD
1 year ago
Apr 17, 2023
Sell 89.8 K USD
Krishnan Krish S
President and CEO
- 1050
 85.5483 USD
1 year ago
Apr 17, 2023
Sell 373 K USD
Krishnan Krish S
President and CEO
- 4298
 86.7964 USD
1 year ago
Apr 17, 2023
Sell 824 K USD
Krishnan Krish S
President and CEO
- 9428
 87.4113 USD
1 year ago
Apr 17, 2023
Sell 860 K USD
Krishnan Krish S
President and CEO
- 9724
 88.4062 USD
1 year ago
Apr 17, 2023
Sell 44.6 K USD
Krishnan Krish S
President and CEO
- 500
 89.1175 USD
1 year ago
Apr 17, 2023
Sell 89.8 K USD
Krishnan Krish S
President and CEO
- 1050
 85.5487 USD
1 year ago
Apr 17, 2023
Sell 373 K USD
Krishnan Krish S
President and CEO
- 4297
 86.7964 USD
1 year ago
Apr 17, 2023
Sell 824 K USD
Krishnan Krish S
President and CEO
- 9429
 87.4114 USD
1 year ago
Apr 17, 2023
Sell 860 K USD
Krishnan Krish S
President and CEO
- 9724
 88.4062 USD
1 year ago
Apr 17, 2023
Sell 44.6 K USD
Krishnan Krish S
President and CEO
- 500
 89.1175 USD
1 year ago
Mar 01, 2023
Sell 3.33 M USD
ROSSI DINO A
Director
- 40000
 83.2493 USD
2 years ago
Jan 17, 2023
Sell 1.66 M USD
Krishnan Suma
President, R&D
- 20617
 80.7019 USD
2 years ago
Jan 17, 2023
Sell 96.5 K USD
Krishnan Suma
President, R&D
- 1186
 81.4062 USD
2 years ago
Jan 17, 2023
Sell 28.6 K USD
Krishnan Suma
President, R&D
- 346
 82.7144 USD
2 years ago
Jan 18, 2023
Sell 165 K USD
Krishnan Suma
President, R&D
- 2048
 80.7531 USD
2 years ago
Jan 18, 2023
Sell 65.5 K USD
Krishnan Suma
President, R&D
- 803
 81.5592 USD
2 years ago
Jan 17, 2023
Sell 1.66 M USD
Krishnan Suma
President, R&D
- 20617
 80.7019 USD
2 years ago
Jan 17, 2023
Sell 96.5 K USD
Krishnan Suma
President, R&D
- 1186
 81.4067 USD
2 years ago
Jan 17, 2023
Sell 28.5 K USD
Krishnan Suma
President, R&D
- 345
 82.7153 USD
2 years ago
Jan 18, 2023
Sell 165 K USD
Krishnan Suma
President, R&D
- 2048
 80.7527 USD
2 years ago
Jan 18, 2023
Sell 65.6 K USD
Krishnan Suma
President, R&D
- 804
 81.5592 USD
2 years ago
Jan 17, 2023
Sell 1.66 M USD
Krishnan Krish S
President and CEO
- 20617
 80.7019 USD
2 years ago
Jan 17, 2023
Sell 96.5 K USD
Krishnan Krish S
President and CEO
- 1186
 81.4062 USD
2 years ago
Jan 17, 2023
Sell 28.6 K USD
Krishnan Krish S
President and CEO
- 346
 82.7144 USD
2 years ago
Jan 18, 2023
Sell 165 K USD
Krishnan Krish S
President and CEO
- 2048
 80.7531 USD
2 years ago
Jan 18, 2023
Sell 65.5 K USD
Krishnan Krish S
President and CEO
- 803
 81.5592 USD
2 years ago
Jan 17, 2023
Sell 1.66 M USD
Krishnan Krish S
President and CEO
- 20617
 80.7019 USD
2 years ago
Jan 17, 2023
Sell 96.5 K USD
Krishnan Krish S
President and CEO
- 1186
 81.4067 USD
2 years ago
Jan 17, 2023
Sell 28.5 K USD
Krishnan Krish S
President and CEO
- 345
 82.7153 USD
2 years ago
Jan 18, 2023
Sell 165 K USD
Krishnan Krish S
President and CEO
- 2048
 80.7527 USD
2 years ago
Jan 18, 2023
Sell 65.6 K USD
Krishnan Krish S
President and CEO
- 804
 81.5592 USD
2 years ago
Jan 04, 2023
Sell 300 K USD
Krishnan Suma
President, R&D
- 3748
 80.0801 USD
2 years ago
Jan 04, 2023
Sell 315 K USD
Krishnan Suma
President, R&D
- 3938
 80.0876 USD
2 years ago
Jan 04, 2023
Sell 300 K USD
Krishnan Krish S
President and CEO
- 3748
 80.0801 USD
2 years ago
Jan 04, 2023
Sell 315 K USD
Krishnan Krish S
President and CEO
- 3938
 80.0876 USD
2 years ago
Dec 29, 2022
Sell 598 K USD
Krishnan Suma
President, R&D
- 7447
 80.2805 USD
2 years ago
Dec 29, 2022
Sell 45.7 K USD
Krishnan Suma
President, R&D
- 563
 81.1055 USD
2 years ago
Jan 03, 2023
Sell 137 K USD
Krishnan Suma
President, R&D
- 1700
 80.3335 USD
2 years ago
Dec 29, 2022
Sell 601 K USD
Krishnan Suma
President, R&D
- 7484
 80.2989 USD
2 years ago
Dec 29, 2022
Sell 42.8 K USD
Krishnan Suma
President, R&D
- 528
 81.102 USD
2 years ago
Jan 03, 2023
Sell 137 K USD
Krishnan Suma
President, R&D
- 1700
 80.326 USD
2 years ago
Dec 29, 2022
Sell 598 K USD
Krishnan Krish S
President and CEO
- 7447
 80.2805 USD
2 years ago
Dec 29, 2022
Sell 45.7 K USD
Krishnan Krish S
President and CEO
- 563
 81.1055 USD
2 years ago
Jan 03, 2023
Sell 137 K USD
Krishnan Krish S
President and CEO
- 1700
 80.3335 USD
2 years ago
Dec 29, 2022
Sell 601 K USD
Krishnan Krish S
President and CEO
- 7484
 80.2989 USD
2 years ago
Dec 29, 2022
Sell 42.8 K USD
Krishnan Krish S
President and CEO
- 528
 81.102 USD
2 years ago
Jan 03, 2023
Sell 137 K USD
Krishnan Krish S
President and CEO
- 1700
 80.326 USD
2 years ago
Dec 16, 2022
Sell 847 K USD
Krishnan Suma
President, R&D
- 10572
 80.0999 USD
2 years ago
Dec 16, 2022
Sell 843 K USD
Krishnan Suma
President, R&D
- 10527
 80.0959 USD
2 years ago
Dec 16, 2022
Sell 847 K USD
Krishnan Krish S
President and CEO
- 10572
 80.0999 USD
2 years ago
Dec 16, 2022
Sell 843 K USD
Krishnan Krish S
President and CEO
- 10527
 80.0959 USD
2 years ago
Nov 23, 2022
Sell 320 USD
Krishnan Suma
President, R&D
- 4
 80.01 USD
2 years ago
Nov 23, 2022
Sell 320 USD
Krishnan Krish S
President and CEO
- 4
 80.01 USD
2 years ago
Nov 08, 2022
Sell 77.3 K USD
Krishnan Suma
President, R&D
- 966
 80.0523 USD
2 years ago
Nov 08, 2022
Sell 65.9 K USD
Krishnan Suma
President, R&D
- 823
 80.0373 USD
2 years ago
Nov 08, 2022
Sell 77.3 K USD
Krishnan Krish S
President and CEO
- 966
 80.0523 USD
2 years ago
Nov 08, 2022
Sell 65.9 K USD
Krishnan Krish S
President and CEO
- 823
 80.0373 USD
2 years ago
Aug 05, 2022
Sell 729 K USD
Krishnan Suma
President, R&D
- 9088
 80.2386 USD
2 years ago
Aug 05, 2022
Sell 721 K USD
Krishnan Krish S
President and CEO
- 8992
 80.2193 USD
3 years ago
Dec 10, 2021
Sell 7.05 M USD
Krishnan Suma
Chief Operating Officer
- 100000
 70.5 USD
3 years ago
Dec 10, 2021
Sell 7.05 M USD
JANNEY DANIEL
Director
- 100000
 70.5 USD
3 years ago
Dec 10, 2021
Sell 7.05 M USD
Krishnan Krish S
President and CEO
- 100000
 70.5 USD
4 years ago
Sep 15, 2020
Sell 667 K USD
Krishnan Suma
Chief Operating Officer
- 14435
 46.2093 USD
4 years ago
Sep 15, 2020
Sell 71.5 K USD
Krishnan Suma
Chief Operating Officer
- 1517
 47.1478 USD
4 years ago
Sep 16, 2020
Sell 451 K USD
Krishnan Suma
Chief Operating Officer
- 9749
 46.2428 USD
4 years ago
Sep 16, 2020
Sell 241 K USD
Krishnan Suma
Chief Operating Officer
- 5142
 46.8486 USD
4 years ago
Sep 17, 2020
Sell 488 K USD
Krishnan Suma
Chief Operating Officer
- 10594
 46.0918 USD
4 years ago
Sep 17, 2020
Sell 347 K USD
Krishnan Suma
Chief Operating Officer
- 7437
 46.6335 USD
4 years ago
Sep 17, 2020
Sell 53.2 K USD
Krishnan Suma
Chief Operating Officer
- 1126
 47.2898 USD
4 years ago
Jun 15, 2020
Sell 313 K USD
Krishnan Suma
Chief Operating Officer
- 7578
 41.3088 USD
4 years ago
Jun 15, 2020
Sell 365 K USD
Krishnan Suma
Chief Operating Officer
- 8652
 42.2361 USD
4 years ago
Jun 15, 2020
Sell 464 K USD
Krishnan Suma
Chief Operating Officer
- 10740
 43.2095 USD
4 years ago
Jun 15, 2020
Sell 504 K USD
Krishnan Suma
Chief Operating Officer
- 11311
 44.5635 USD
4 years ago
Jun 15, 2020
Sell 528 K USD
Krishnan Suma
Chief Operating Officer
- 11719
 45.0706 USD
4 years ago
May 15, 2020
Sell 221 K USD
Krishnan Krish S
President and CEO
- 3842
 57.4282 USD
4 years ago
May 15, 2020
Sell 723 K USD
Krishnan Krish S
President and CEO
- 12445
 58.0854 USD
4 years ago
May 15, 2020
Sell 623 K USD
Krishnan Krish S
President and CEO
- 10552
 59.029 USD
4 years ago
May 18, 2020
Sell 162 K USD
Krishnan Krish S
President and CEO
- 2900
 55.985 USD
4 years ago
May 18, 2020
Sell 386 K USD
Krishnan Krish S
President and CEO
- 6784
 56.838 USD
4 years ago
May 18, 2020
Sell 310 K USD
Krishnan Krish S
President and CEO
- 5371
 57.6302 USD
4 years ago
May 18, 2020
Sell 107 K USD
Krishnan Krish S
President and CEO
- 1805
 59.113 USD
4 years ago
May 18, 2020
Sell 376 K USD
Krishnan Krish S
President and CEO
- 6301
 59.7278 USD
4 years ago
Mar 16, 2020
Sell 103 K USD
Krishnan Suma
Chief Operating Officer
- 2559
 40.1384 USD
4 years ago
Mar 17, 2020
Sell 436 K USD
Krishnan Suma
Chief Operating Officer
- 10780
 40.4851 USD
4 years ago
Mar 17, 2020
Sell 57.6 K USD
Krishnan Suma
Chief Operating Officer
- 1396
 41.2658 USD
4 years ago
Mar 17, 2020
Sell 168 USD
Krishnan Suma
Chief Operating Officer
- 4
 42.03 USD
4 years ago
Mar 18, 2020
Sell 26.5 K USD
Krishnan Suma
Chief Operating Officer
- 659
 40.2018 USD
4 years ago
Feb 18, 2020
Sell 466 K USD
Krishnan Krish S
President and CEO
- 7481
 62.2594 USD
4 years ago
Feb 18, 2020
Sell 289 K USD
Krishnan Krish S
President and CEO
- 4588
 62.9754 USD
4 years ago
Feb 18, 2020
Sell 38.4 K USD
Krishnan Krish S
President and CEO
- 600
 63.9533 USD
4 years ago
Feb 19, 2020
Sell 1.01 M USD
Krishnan Krish S
President and CEO
- 16033
 62.6962 USD
4 years ago
Feb 19, 2020
Sell 165 K USD
Krishnan Krish S
President and CEO
- 2617
 63.1466 USD
4 years ago
Feb 20, 2020
Sell 131 K USD
Krishnan Krish S
President and CEO
- 2192
 59.596 USD
4 years ago
Feb 20, 2020
Sell 608 K USD
Krishnan Krish S
President and CEO
- 10022
 60.7054 USD
4 years ago
Feb 20, 2020
Sell 219 K USD
Krishnan Krish S
President and CEO
- 3561
 61.5209 USD
4 years ago
Feb 20, 2020
Sell 181 K USD
Krishnan Krish S
President and CEO
- 2906
 62.3769 USD
5 years ago
Dec 16, 2019
Sell 463 K USD
Krishnan Suma
Chief Operating Officer
- 7373
 62.8444 USD
5 years ago
Dec 16, 2019
Sell 471 K USD
Krishnan Suma
Chief Operating Officer
- 7396
 63.6235 USD
5 years ago
Dec 16, 2019
Sell 376 K USD
Krishnan Suma
Chief Operating Officer
- 5856
 64.2782 USD
5 years ago
Dec 16, 2019
Sell 21.1 K USD
Krishnan Suma
Chief Operating Officer
- 322
 65.6042 USD
5 years ago
Dec 17, 2019
Sell 487 K USD
Krishnan Suma
Chief Operating Officer
- 8138
 59.8676 USD
5 years ago
Dec 17, 2019
Sell 532 K USD
Krishnan Suma
Chief Operating Officer
- 8799
 60.461 USD
5 years ago
Dec 17, 2019
Sell 55 K USD
Krishnan Suma
Chief Operating Officer
- 891
 61.7222 USD
5 years ago
Dec 17, 2019
Sell 115 K USD
Krishnan Suma
Chief Operating Officer
- 1834
 62.7907 USD
5 years ago
Dec 17, 2019
Sell 17.7 K USD
Krishnan Suma
Chief Operating Officer
- 279
 63.3472 USD
5 years ago
Dec 18, 2019
Sell 71.4 K USD
Krishnan Suma
Chief Operating Officer
- 1200
 59.4893 USD
5 years ago
Dec 18, 2019
Sell 61.2 K USD
Krishnan Suma
Chief Operating Officer
- 1017
 60.1921 USD
5 years ago
Dec 18, 2019
Sell 55.2 K USD
Krishnan Suma
Chief Operating Officer
- 900
 61.2811 USD
5 years ago
Dec 18, 2019
Sell 361 K USD
Krishnan Suma
Chief Operating Officer
- 5756
 62.6463 USD
5 years ago
Dec 18, 2019
Sell 15.1 K USD
Krishnan Suma
Chief Operating Officer
- 239
 63.3143 USD
5 years ago
Nov 15, 2019
Sell 591 K USD
Krishnan Krish S
President and CEO
- 11895
 49.7242 USD
5 years ago
Nov 15, 2019
Sell 577 K USD
Krishnan Krish S
President and CEO
- 11386
 50.6903 USD
5 years ago
Nov 15, 2019
Sell 237 K USD
Krishnan Krish S
President and CEO
- 4598
 51.4696 USD
5 years ago
Nov 18, 2019
Sell 53.3 K USD
Krishnan Krish S
President and CEO
- 1046
 50.9768 USD
5 years ago
Nov 18, 2019
Sell 545 K USD
Krishnan Krish S
President and CEO
- 10513
 51.8162 USD
5 years ago
Nov 18, 2019
Sell 426 K USD
Krishnan Krish S
President and CEO
- 8080
 52.6787 USD
5 years ago
Nov 18, 2019
Sell 112 K USD
Krishnan Krish S
President and CEO
- 2082
 53.8618 USD
5 years ago
Nov 18, 2019
Sell 21.8 K USD
Krishnan Krish S
President and CEO
- 400
 54.38 USD
5 years ago
Aug 29, 2019
Sell 2.6 M USD
JANNEY DANIEL
Director
- 55794
 46.61 USD
5 years ago
Aug 29, 2019
Sell 33.2 K USD
JANNEY DANIEL
Director
- 700
 47.5 USD
5 years ago
Aug 30, 2019
Sell 1.49 M USD
JANNEY DANIEL
Director
- 32190
 46.18 USD
6 years ago
Oct 18, 2018
Bought 500 K USD
Krishnan Suma
Chief Operating Officer
+ 25000
 20 USD
6 years ago
Oct 18, 2018
Bought 500 K USD
Krishnan Krish S
President and CEO
+ 25000
 20 USD
6 years ago
Jun 06, 2018
Bought 12.7 K USD
Krishnan Suma
Chief Operating Officer
+ 1018
 12.45 USD
6 years ago
Jun 06, 2018
Bought 146 K USD
Krishnan Suma
Chief Operating Officer
+ 13116
 11.145 USD
6 years ago
Jun 05, 2018
Bought 117 K USD
Krishnan Suma
Chief Operating Officer
+ 10866
 10.7452 USD
6 years ago
May 22, 2018
Bought 30.1 K USD
Riley Antony A
Chief Financial Officer
+ 2800
 10.75 USD
6 years ago
May 09, 2018
Bought 93.8 K USD
NORBY R DOUGLAS
Director
+ 9000
 10.42 USD
6 years ago
Mar 19, 2018
Bought 550 K USD
Krishnan Krish S
President and CEO
+ 50000
 11 USD
7 years ago
Sep 22, 2017
Bought 2 M USD
JANNEY DANIEL
Director
+ 200000
 10 USD
7 years ago
Sep 22, 2017
Bought 1 M USD
Krishnan Suma
Chief Operating Officer
+ 100000
 10 USD
7 years ago
Sep 22, 2017
Bought 1 M USD
Krishnan Krish S
President and CEO
+ 100000
 10 USD
7. News
Krystal Biotech: Blockbuster Ambitions For Topical Gene Therapy Krystal Biotech's VYJUVEK, a groundbreaking gene therapy for DEB, achieved $83.8M in Q3 2024 sales, doubling from Q4 2023. Trading at 57x 2024 earnings, Krystal's stock appears expensive but is projected to double earnings by 2025. With imminent EU and Japanese market expansion, Krystal seems poised to outperform analyst's expectations for growth. seekingalpha.com - 3 weeks ago
KRYS Reports Upbeat Initial Data From Lung Cancer Study of KB707 Krystal Biotech reports initial data from a phase I/II study showing therapeutic benefit in NSCLC patients treated with its immunotherapy candidate, KB707. zacks.com - 1 month ago
Krystal Biotech Announces Early Evidence of Monotherapy Activity in Heavily Pre-Treated Patients with Advanced Non-Small Cell Lung Cancer Preliminary clinical data in post-anti-PD-1 NSCLC patients demonstrated a 27% ORR and 73% DCR in monotherapy trial Monotherapy activity with inhaled KB707 provides further evidence of successful repeat administration of HSV-1 based inhaled lung gene delivery and builds on recent clinical data update for CF and AAT deficiency respiratory disease programs PITTSBURGH, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, announced today initial clinical results from its ongoing KYANITE-1 study evaluating inhaled KB707 in patients with solid tumors of the lung. KB707 administered via inhalation demonstrated early evidence of monotherapy activity that was most pronounced in patients with advanced non-small cell lung cancer (NSCLC), where an objective response rate (ORR) of 27% and disease control rate (DCR) of 73% were observed as of data cut-off on December 6, 2024. globenewswire.com - 1 month ago
KRYS Stock Down on Initial Clinical Updates on KB407 & KB408 Krystal Biotech posts initial clinical updates on its two pipeline candidates, KB407 and KB408, which are being developed to treat rare respiratory diseases. zacks.com - 1 month ago
Krystal Biotech Provides Update on EMA's Ongoing Regulatory Review of B-VEC for Dystrophic Epidermolysis Bullosa CHMP opinion now expected in 1Q 2025 No Major Objections outstanding; continue to expect Germany launch in 2Q 2025 PITTSBURGH, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc . (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) cancelled the Oral Explanation regarding the Company's Marketing Authorization Application for beremagene geperpavec-svdt (B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB) that was scheduled for December 6, 2024, and asked the Company to submit written responses to the remaining outstanding issues. globenewswire.com - 1 month ago
Why Is Krystal Biotech (KRYS) Up 6.6% Since Last Earnings Report? Krystal Biotech (KRYS) reported earnings 30 days ago. What's next for the stock? zacks.com - 1 month ago
Krystal Biotech to Present at Upcoming Investor Conferences PITTSBURGH, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc . (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that Krish S. Krishnan, Chairman and Chief Executive Officer, will take part in fireside chats and host investor meetings at two upcoming investor conferences: globenewswire.com - 1 month ago
Krystal Biotech to Present at Guggenheim Securities Healthcare Innovation Conference PITTSBURGH, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc . (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the Company will participate in the Guggenheim Securities Healthcare Innovation Conference on November 12, 2024, in Boston. Krish S. Krishnan, Chairman and Chief Executive Officer, will take part in a fireside chat scheduled at 1:30 pm ET and host investor meetings throughout the day. globenewswire.com - 2 months ago
Krystal Q3 Earnings and Sales Top Estimates, Vyjuvek Gains Traction KRYS beat on both earnings and sales in the third quarter of 2024. Lead drug Vyjuvek's launch in the United States shows strong uptake. zacks.com - 2 months ago
Krystal Biotech, Inc. (KRYS) Q3 2024 Earnings Call Transcript Krystal Biotech, Inc. (NASDAQ:KRYS ) Q3 2024 Earnings Conference Call November 4, 2024 8:30 AM ET Company Participants Stéphane Paquette - VP, Corporate Development Krish Krishnan - Chairman and CEO Suma Krishnan - President, Research and Development Jennifer McDonough - SVP, Patient Access, Analytics and Operations Christine Wilson - SVP and Head, U.S. Sales and Marketing Kate Romano - CAO Conference Call Participants Alec Stranahan - BOA Yigal Nochomovitz - Citigroup Ritu Baral - TD Cowen Sami Corwin - William Blair Gavin Clark-Gartner - Evercore ISI Dae Gon Ha - Stifel Debjit Chattopadhyay - Guggenheim Securities Andrea Newkirk - Goldman Sachs Operator Thank you for standing by and welcome to Krystal Biotech's Third Quarter Earnings Conference Call. [Operator Instructions] As a reminder, today's conference is being recorded. seekingalpha.com - 2 months ago
Krystal Biotech, Inc. (KRYS) Beats Q3 Earnings and Revenue Estimates Krystal Biotech, Inc. (KRYS) came out with quarterly earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.84 per share. This compares to loss of $0.67 per share a year ago. zacks.com - 2 months ago
Krystal Biotech, Inc. (KRYS) to Report Q3 Results: Wall Street Expects Earnings Growth Krystal Biotech (KRYS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com - 2 months ago
8. Profile Summary

Krystal Biotech, Inc. KRYS

image
COUNTRY US
INDUSTRY Biotechnology
MARKET CAP $ 4.27 B
Dividend Yield 0.00%
Description Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing KB105 that is in Phase I/II clinical study for treating patients with deficient autosomal recessive congenital ichthyosis; KB301, which is in Phase I/II clinical stage for treating wrinkles and other presentations of aged or damaged skin; KB407 that is in preclinical stage for cystic fibrosis; and KB104, which is in preclinical stage for netherton syndrome. Its discovery stage product candidates include KB5xx for treating chronic skin diseases, KB3xx to treat aesthetic skin conditions, and KB3xx product. Krystal Biotech, Inc. was founded in 2015 and is headquartered in Pittsburgh, Pennsylvania.
Contact 2100 Wharton Street, Pittsburgh, PA, 15203 https://www.krystalbio.com
IPO Date Sept. 20, 2017
Employees 229
Officers Dr. Stephane Paquette Ph.D. Vice President of Corporate Development Mr. David Chien Senior Vice President of Clinical Development Mr. Krish S. Krishnan M.B.A., M.S. Founder, Chairman, President & Chief Executive Officer Mr. John Karakkal Vice President of North American Sales & Marketing Ms. Suma M. Krishnan Founder, President of R&D and Director Ms. Kathryn A. Romano CPA Executive Vice President & Chief Accounting Officer Mr. John Thomas General Counsel & Corporate Secretary Mr. Laurent Goux Senior Vice President & GM of Europe Ms. Christine Wilson Head of U.S. Sales & Marketing Mr. Josh Suskin Director of Human Resources & Operations